Effects of gabapentin on anxiety induced by simulated public speaking

J Psychopharmacol. 2003 Jun;17(2):184-8. doi: 10.1177/0269881103017002006.

Abstract

The effects of gabapentin, 400 mg and 800 mg, on anxiety induced by simulated public speaking (SPS) were investigated. Thirty-two normal male volunteers (aged 17-30 years) had their anxiety and mood evaluated by self-scales [Visual Analogue Mood Scale (VAMS) and Profile of Mood State (POMS)] during the SPS procedure. Physiological measures (heart rate and blood pressure) were taken. Treatment with gabapentin at 800 mg attenuated the anxiety of subjects that had a decrease on the VAMS item calm-excite. In addition, volunteers that received gabapentin at 400 mg and 800 mg showed a decrease in the hostility score in POMS. Our results suggest, in agreement with other studies, an anxiolytic potential to gabapentin.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / administration & dosage
  • Acetates / adverse effects
  • Acetates / therapeutic use*
  • Adolescent
  • Adult
  • Amines*
  • Anti-Anxiety Agents / administration & dosage
  • Anti-Anxiety Agents / adverse effects
  • Anti-Anxiety Agents / therapeutic use*
  • Anxiety / drug therapy*
  • Anxiety / psychology
  • Blood Pressure
  • Cyclohexanecarboxylic Acids*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Gabapentin
  • Heart Rate
  • Humans
  • Male
  • Speech*
  • gamma-Aminobutyric Acid*

Substances

  • Acetates
  • Amines
  • Anti-Anxiety Agents
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin